Guardian Dermatology, P.C.

Guardian Dermatology, P. C. is a US-based company focused on advanced dermatological care, providing innovative diagnostic and therapeutic solutions for various skin conditions, serving both clinical and at-home markets. Founded in 2021 and headquartered in Helena, US, Guardian Dermatology specializes in dermatological products and services.

The company completed its sole funding round and was most recently acquired by Epiphany Dermatology, P. A. on February 3, 2026. Financial terms of the acquisition were not disclosed.

Guardian Dermatology specializes in a range of innovative dermatological products and services aimed at addressing various skin conditions. Their core offerings include advanced diagnostic tools, therapeutic treatments, and skincare solutions designed for both clinical and at-home use. The company primarily focuses on end users such as dermatologists, skincare professionals, and patients seeking effective treatments for acne, eczema, psoriasis, and other skin disorders. The products have been strategically developed to enhance the efficiency of diagnosis and treatment processes, ensuring a comprehensive approach to skin health.

Guardian Dermatology markets its products across multiple geographical regions, including North America, Europe, and Asia, catering to a diverse clientele that values high-quality dermatological care. Guardian Dermatology operates on a transactional revenue model that includes both direct-to-consumer and B2B strategies. The company engages in partnerships with healthcare providers and clinics, enabling them to offer Guardian's products as part of their treatment regimens. Revenue is generated through the sale of individual products, often bundled as part of a complete skincare regimen.

Specific pricing structures are established for flagship products, which may include premium skincare lines and patented therapeutic solutions that reflect the company's commitment to quality and efficacy. The company facilitates transactions through subscription services for ongoing product replenishment, ensuring consistent revenue streams and fostering long-term customer relationships. Looking ahead, Guardian Dermatology plans to expand its product offerings, with new innovations scheduled for launch by late 2026. The company is also targeting expansion into key markets in Latin America and Asia by the end of 2027.

The recent acquisition by Epiphany Dermatology, P. A. will provide additional resources and support for these initiatives, facilitating further development and market penetration.